化学
整合素
化学合成
立体化学
环肽
结构-活动关系
生物化学
体外
受体
肽
作者
Valentina Giraldi,Andrea M. Maurizio,Martina Cirillo,Paolo Magnone,Emanuela Fedele,Andrea Bedini,Monica Baiula,Daria Giacomini
标识
DOI:10.1016/j.ejmech.2025.117965
摘要
: The immune system depends on integrins for adhesion and migration during leukocyte trafficking and for intracellular signalling. There is a causal relationship between dysregulation of integrin expression and the onset of pathological conditions, such as autoimmune diseases, inflammation, cancer, and infections. Therefore, integrins, such as α 4 β 1 , are considered important therapeutic targets. In this study, a series of novel compounds were synthesized and evaluated for affinity and potency towards α 4 β 1 , and selectivity towards α 5 β 1 , and α M β 2 integrins. Three compounds 3 , 4 , and 8 showed excellent binding affinities (K i < 10 nM) for α 4 β 1 . In cell adhesion assays these three ligands behaved as antagonists of α 4 β 1 , as confirmed by integrin-mediated intracellular signalling with a functional selectivity over ERK1/2 signalling pathway. Notably, compound 4 , a proline derivative, was an antagonist against α 4 β 1 (IC 50 15 ± 3 nM) and an agonist against α M β 2 integrin (EC 50 23 ± 5 nM). Compound 2 , a fluorinated β-lactam derivative, was a selective and potent agonist of α 5 β 1 (EC 50 45.98 ± 7.92 nM). Compound 5 , although it seems to bind to a different site compared to LDV in α 4 β 1 integrin, showed an agonist behaviour in cell adhesion mediated by α 4 β 1 and α 5 β 1 integrin (EC 50 25 ± 3 and 4.8 ± 3.4 nM, respectively) and in activating α 4 β 1 integrin-mediated ERK1/2 and Akt phosphorylation. Compound 8 was the most potent agonist of the series against α M β 2 (EC 50 1.4 ± 0.2 nM). Overall, the present study provides new insights into the effects of new integrin ligands that could be considered as potential lead compounds for therapeutic applications in inflammatory diseases and cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI